Beth Seidenberg
Directeur/Membre du Conseil chez PROGYNY, INC.
Fortune : 10 M $ au 30/04/2024
Profil
Le Dr Beth C. Seidenberg, MD, est directrice générale de Westlake Biopartners LLC, directrice indépendante de Vera Therapeutics, Inc. et d'Atara Biotherapeutics, Inc. et présidente de Progyny, Inc. et de Sagimet Biosciences, Inc. et associée et conseillère de Kleiner Perkins Caufield & Byers LLC. Elle siège au conseil d'administration de Expansion Therapeutics, Inc, Vera Therapeutics, Inc, Atara Biotherapeutics, Inc, ACELYRIN, Inc, Arsenal Biosciences, Inc, Auxogyn, Inc, Breathe Technologies, Inc, Cell Design Labs, Inc, Kyverna Therapeutics, Inc, Mango Health, Inc, Spruce Health, Inc, Tmunity Therapeutics, Inc et True North Therapeutics, Inc. Le Dr Seidenberg a été précédemment employé en tant que directeur indépendant par Epizyme, Inc. et en tant que directeur médical et vice-président directeur du développement mondial par Amgen, Inc. et vice-président directeur du développement mondial par Bristol Myers Squibb Co, vice-présidente chargée de l'immunologie, des maladies pulmonaires et de la dermatologie chez Merck Research Laboratories Massachusetts LLC, présidente d'Arresto BioSciences, Inc. et de Flexus Biosciences, Inc. et cadre supérieur chargé de la recherche et du développement chez Merck & Co, Inc. et chercheuse au National Institutes of Health. Elle a également été membre du conseil d'administration de Practice Fusion, Inc, ARMO BioSciences, Inc, Tesaro, Inc, BioCryst Pharmaceuticals, Inc, iPierian, Inc, Livongo Health, Inc, Rapt Therapeutics, Inc et RedBrick Health Corp. Elle a obtenu son diplôme de premier cycle au Barnard College et un doctorat à l'école de médecine Leonard M. Miller de l'université de Miami.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROGYNY, INC.
0,28% | 23/05/2024 | 271 322 ( 0,28% ) | 9 M $ | 30/04/2024 |
| 18/07/2023 | 131 643 ( 0,43% ) | 516 041 $ | 30/04/2024 | |
ACELYRIN, INC.
0,06% | 09/05/2023 | 60 000 ( 0,06% ) | 254 400 $ | 30/04/2024 |
| 31/05/2023 | 116 083 ( 0,10% ) | 81 258 $ | 30/04/2024 | |
| 15/05/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Beth Seidenberg
| Sociétés | Poste | Début |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Directeur/Membre du Conseil | 01/04/2007 |
| KYVERNA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2018 |
| PROGYNY, INC. | Directeur/Membre du Conseil | 01/01/2022 |
| ACELYRIN, INC. | Directeur/Membre du Conseil | 01/10/2020 |
| VERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2016 |
Kleiner Perkins Caufield & Byers LLC
 Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Consultant / Advisor | 01/05/2005 |
Mango Health, Inc.
 Mango Health, Inc. Packaged SoftwareTechnology Services Mango Health, Inc. provides mobile health application. Its applications allow the user to create a routine for healthy habits which includes taking medication on time, recording weight and checking blood pressure. The company was founded by Jason Oberfest and Gerald Chong in 2012 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - |
Spruce Health, Inc.
 Spruce Health, Inc. Packaged SoftwareTechnology Services Spruce Health, Inc. provides medical mobile application services. It offers Spruce, a mobile application that connects patients with the board-certified dermatologist in California, Florida, New York, and Pennsylvania. The firm’s applications allow patients to share photos of the symptoms, skin and medical history information with the dermatologist, as well as enable dermatologists to provide the patients with the personalized treatment plan. The company was founded by Ray Bradford in August 2013 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | - |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Beth Seidenberg
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Beth Seidenberg
| Barnard College | Undergraduate Degree |
| The University of Miami Leonard M. Miller School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 11 |
|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| SAGIMET BIOSCIENCES INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| KYVERNA THERAPEUTICS, INC. | Health Technology |
| PROGYNY, INC. | Commercial Services |
| RAPT THERAPEUTICS, INC. | Health Technology |
| ACELYRIN, INC. | Health Technology |
| VERA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 26 |
|---|---|
Kleiner Perkins Caufield & Byers LLC
Kleiner Perkins Caufield & Byers LLC Investment ManagersFinance Kleiner Perkins Caufield & Byers LLC (Kleiner Perkins Caufield & Byers) is a venture capital firm founded in 1972 by Eugene Kleiner, Thomas Perkins, Brook Byers and Frank J. Caufield. The firm is headquartered in California, US. | Finance |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Arresto BioSciences, Inc.
 Arresto BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Arresto Biosciences, Inc. is a biotech company that develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. The company was founded by Amato Giaccia, Michael T. Longaker and Geoffrey C. Gurtner in 2007 and is headquartered in Palo Alto, California. | Commercial Services |
Breathe Technologies, Inc.
 Breathe Technologies, Inc. Medical SpecialtiesHealth Technology Breathe Technologies, Inc. develops and manufactures chronic obstructive pulmonary disease therapy devices. The firm offers NIOV product. It provides ultra-lightweight, compact and wearable ventilators designed to improve breathing and to facilitate the mobility required for normal activities of daily life. The company was founded in January 2005 by Lutz Freitag, Spencer J. Volk and Gregory J. Kapust and is headquartered in Irvine, CA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
Auxogyn, Inc.
 Auxogyn, Inc. BiotechnologyHealth Technology Auxogyn, Inc. provides novel scientific and development biotechnology services. It is focused on advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The firm's first product, the Eeva test, is designed to provide quantitative information regarding embryo development to assist IVF clinicians in optimizing the treatment path for their patients undergoing IVF procedures. The company was founded by Renee A. Reijo Pera, Barry Behr, Thomas Baer, Connie Wong, Lissa A. Goldenstein and Kevin Loewke in 2008 and is headquartered in Menlo Park, CA. | Health Technology |
RedBrick Health Corp.
 RedBrick Health Corp. Internet Software/ServicesTechnology Services RedBrick Health Corp. provides health engagement and behavior change solutions. It offers health assessment, biometric screening, health advising, phone coaching, multi modal programs, program integration, communications and reporting solutions. The firm serves large, self-insured employers, insurers, brokers and strategic distribution partners. The company was founded by Kyle Rolfing and Kurt Cigielski in 2006 and is headquartered in Minneapolis, MN. | Technology Services |
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Practice Fusion, Inc.
 Practice Fusion, Inc. Packaged SoftwareTechnology Services Practice Fusion, Inc. engages in the development of cloud-based electronic health record platform for doctors and patients. Its platform features include e-Prescribing, medical charting, scheduling, lab integrations, patient management, patient health record, and mobile EMR and support. The company was founded by Matthew C. Douglass, Jonathan Malek, Alan Wong, and Ryan Howard in 2005 and is headquartered in San Francisco, CA. | Technology Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology ierian, Inc. developed and manufactured biopharmaceutical products. The firm's lead antibody, IPN007, represents a new approach to treating neurodegenerative disease by targeting a novel form of secreted Tau protein. The company was founded in 2007 and is headquartered in South San Francisco, CA. | Health Technology |
Arsenal Biosciences, Inc.
 Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Technology Services |
Mango Health, Inc.
Mango Health, Inc. Packaged SoftwareTechnology Services Mango Health, Inc. provides mobile health application. Its applications allow the user to create a routine for healthy habits which includes taking medication on time, recording weight and checking blood pressure. The company was founded by Jason Oberfest and Gerald Chong in 2012 and is headquartered in San Francisco, CA. | Technology Services |
Spruce Health, Inc.
Spruce Health, Inc. Packaged SoftwareTechnology Services Spruce Health, Inc. provides medical mobile application services. It offers Spruce, a mobile application that connects patients with the board-certified dermatologist in California, Florida, New York, and Pennsylvania. The firm’s applications allow patients to share photos of the symptoms, skin and medical history information with the dermatologist, as well as enable dermatologists to provide the patients with the personalized treatment plan. The company was founded by Ray Bradford in August 2013 and is headquartered in San Francisco, CA. | Technology Services |
Cell Design Labs, Inc.
Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Health Technology |
Livongo Health, Inc.
 Livongo Health, Inc. Miscellaneous Commercial ServicesCommercial Services Livongo Health, Inc. engages in the development and operation of consumer digital health platform. It offers Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008 and is headquartered in Mountain View, CA. | Commercial Services |
Expansion Therapeutics, Inc.
 Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Health Technology |
Flexus Biosciences, Inc.
 Flexus Biosciences, Inc. BiotechnologyHealth Technology Flexus Biosciences, Inc. provides cancer therapeutics through innovative apps. It engages in leveraging unexploited insights in immunology to discover Agents for Reversal of Tumor Immunosuppression. The company was founded by Terry J. Rosen and Juan C. Jaen in 2013 and is headquartered in San Carlos, CA. | Health Technology |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
Westlake Biopartners LLC
 Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners LLC (Westlake Biopartners) is a venture capital firm founded in 2018. The firm is headquartered in Westlake Village, California. | Finance |
Jamanda Ltd.
 Jamanda Ltd. Financial ConglomeratesFinance Jamanda Ltd. is an investment holding British company founded in 2016. The private company is based in Grantham, UK. The company's main function is to hold investments. | Finance |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Health Technology |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Electra Therapeutics, Inc. is a clinical stage biotechnology company that develops therapies for the treatment of immunological diseases and cancer. The company is based in San Francisco, CA. The company's lead product candidate, ela026, is a monoclonal antibody that targets sirp on the cell surface of and t cells, and precisely depletes pathological immune cells. Electra currently has one program in clinical development and additional preclinical programs. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Health Technology |
Kate Therapeutics, Inc.
 Kate Therapeutics, Inc. BiotechnologyHealth Technology The American company is focused on developing gene therapies to treat muscle and heart diseases using adeno-associated virus (AAV) technology. Kate Therapeutics is applying novel technology platforms to address the limitations of current gene therapies, including tissue-specific delivery and gene regulation. The company's breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies. The company was founded by Eric Wang, Mark Fielden, Alan H. Beggs, Sharif Tabebordbar, Kevin M. Forrest, and Kevin M. Forrest has been the CEO since incorporation. | Health Technology |
